08/27/2025
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2025
3:30 PM | Allarity Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/16/2025
6:20 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2025
10:51 AM | Allarity Therapeutics (Issuer)
Ervin Jeffrey S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/07/2025
7:43 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2025
3:05 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2025
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/24/2025
7:07 AM | Allarity Therapeutics (Filer)
| Form RW | |
06/11/2025
3:10 PM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2025
7:09 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2025
7:05 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ALLR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Allarity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/13/2025
7:01 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2025
4:27 PM | Allarity Therapeutics (Filer)
| Form DEF 14A | |
04/30/2025
4:28 PM | Allarity Therapeutics (Filer)
| Form DEFA14A | |
04/28/2025
7:01 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
7:01 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2025
7:01 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2025
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2025
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
7:17 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2025
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
7:06 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2025
6:55 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2025
7:07 PM | Allarity Therapeutics (Issuer)
McLaughlin Gerald W. (Reporting)
| Form 4/A | |
01/24/2025
7:09 PM | Allarity Therapeutics (Issuer)
Benjamin Laura (Reporting)
| Form 4/A | |
01/24/2025
7:10 PM | Allarity Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
| Form 4/A | |
01/24/2025
3:12 PM | Allarity Therapeutics (Issuer)
Benjamin Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:13 PM | Allarity Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:14 PM | Allarity Therapeutics (Issuer)
McLaughlin Gerald W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:16 PM | Allarity Therapeutics (Issuer)
Jensen Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:17 PM | Allarity Therapeutics (Issuer)
Epshinsky Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:18 PM | Allarity Therapeutics (Issuer)
Graff Jeremy R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:17 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
8:24 PM | 3i, LP (Filed by)
Allarity Therapeutics (Subject)
| Form SC 13G/A | |
10/23/2024
7:01 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
4:32 PM | Allarity Therapeutics (Issuer)
Graff Jeremy R. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/01/2024
4:34 PM | Allarity Therapeutics (Issuer)
Graff Jeremy R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:05 PM | Allarity Therapeutics (Issuer)
Epshinsky Alexander (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
This is my Christian duty (Ad) “This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth.
Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation. Watch Jim Rickards reveal the Old Testament Wealth Code |
09/17/2024
7:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
7:53 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
8:15 AM | Allarity Therapeutics (Filer)
| Form 8-K/A | |
09/09/2024
8:00 AM | Allarity Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
4:57 PM | Allarity Therapeutics (Subject)
Olmsted Investments LLC (Filed by)
| Form SCHEDULE 13G | |
MarketBeat All Access